Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.

F Kocher; A Seeber; L Weiss; F Romeder; J Szkandera; T Kuhr; S Kostner; P Pichler; T Jager; Richard Greil; T Brodowicz

Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.

F Kocher, A Seeber, L Weiss, F Romeder, J Szkandera, T Kuhr, S Kostner, P Pichler, T Jager, Richard Greil, T Brodowicz

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	37
Issue number	15
Publication status	Published - 2019
Event	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, IL Duration: 31 May 2019 → 4 Jun 2019

Cite this

Kocher, F., Seeber, A., Weiss, L., Romeder, F., Szkandera, J., Kuhr, T., Kostner, S., Pichler, P., Jager, T., Greil, R., & Brodowicz, T. (2019). Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria. JOURNAL OF CLINICAL ONCOLOGY , 37(15).

Kocher, F ; Seeber, A ; Weiss, L et al. / Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria. In: JOURNAL OF CLINICAL ONCOLOGY 2019 ; Vol. 37, No. 15.

@article{5c8d1e89eac34c889b5e6c206fc688e2,

title = "Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.",

author = "F Kocher and A Seeber and L Weiss and F Romeder and J Szkandera and T Kuhr and S Kostner and P Pichler and T Jager and Richard Greil and T Brodowicz",

year = "2019",

language = "English",

volume = "37",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "15",

note = "Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) ; Conference date: 31-05-2019 Through 04-06-2019",

}

Kocher, F, Seeber, A, Weiss, L, Romeder, F, Szkandera, J, Kuhr, T, Kostner, S, Pichler, P, Jager, T, Greil, R & Brodowicz, T 2019, 'Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.', JOURNAL OF CLINICAL ONCOLOGY , vol. 37, no. 15.

Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria. / Kocher, F; Seeber, A; Weiss, L et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 37, No. 15, 2019.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.

AU - Kocher, F

AU - Seeber, A

AU - Weiss, L

AU - Romeder, F

AU - Szkandera, J

AU - Kuhr, T

AU - Kostner, S

AU - Pichler, P

AU - Jager, T

AU - Greil, Richard

AU - Brodowicz, T

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 0732-183X

VL - 37

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 15

T2 - Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Y2 - 31 May 2019 through 4 June 2019

ER -

Kocher F, Seeber A, Weiss L, Romeder F, Szkandera J, Kuhr T et al. Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria. JOURNAL OF CLINICAL ONCOLOGY . 2019;37(15).